Skip to main content
SpringerLink
Log in

Antagonism of the hypothermic effect of clozapine in mice by centrally-active α2-adrenergic antagonists and α1-adrenergic agonists

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Hypothermia induced by either clozapine or clonidine in mice was blocked by the α2-adrenergic antagonists yohimbine, idazoxan, CH-38083, SKF 86466, and L-657,743. These effects were dose related, and the ID50 values for inhibition of clozapine- or clonidine-induced hypothermia were fairly comparable. The order of potency for blocking clonidine-induced hypothermia was: L-657,743>CH-38083>yohimbine>idazoxan>SKF 86466. A very similar blockade hierarchy for clozapine-induced hypothermia was observed, with the order of the two most effective compounds being reversed. Hypothermia induced by either compound was not blocked by the peripherally-acting, selective α2-adrenergic antagonist, L-659,066, indicating that blockade by the other compounds occurred centrally. The centrally-acting, α1-adrenergic agonists St 587, cirazoline, and SKF 89748 were very effective in blocking the response to clozapine, but ineffective in antagonizing clonidine-induced hypothermia. The ED50 values for the blockade of this response to clozapine, however, did not correlate with their reported potencies in stimulating either peripheral or central α1-adrenergic receptors. This indicates that clozapine-induced hypothermia in mice is not a suitable model for evaluating the properties of central α1-adrenergic compounds. Moreover, since the clonidine-induced hypothermia is not influenced by α1-adrenergic agonists, this paradigm is preferable to clozapine-induced hypothermia in the assessment of α2-adrenergic antagonism. The ability of α2-adrenergic antagonists to block clozapine-induced hypothermia may result from the central overflow of norepinephrine, which is known to be brought about by this group of compounds. The neurochemical mechanism responsible for the anti-clozapine effect of the α1-adrenergic agonists in mice is not clear. An as yet unknown property of these compounds, unrelated to α1-agonism, may have to be considered. An interaction of these compounds at the high-affinity clozapine binding site is a possibility. Discovery of antagonists to clozapine may help to elucidate the mechanism of action of this atypical neuroleptic.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anden NE, Pauksens K, Svensson K (1982) Selective blockade of brain α2-autoreceptors by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine. J Neural Transm 55:111–120

    Article  PubMed  Google Scholar 

  • Burki HR (1980) Inhibition of3H-clozapine binding in rat brain after oral administration of neuroleptics. Life Sci 26:2187–2193

    Article  PubMed  Google Scholar 

  • Clineschmidt BV, Pettibone DJ, Lotti VJ, Hucker HB, Sweeney BM, Reiss DR, Lis EV, Huff JR, Vacca J (1988) A peripherally acting α2-adrenoceptor antagonist: L659,066. J Pharmacol Exp Ther 245:32–40

    PubMed  Google Scholar 

  • De Jonge A, Van Meel CA, Timmermans PBMWM, Van Zwieten PA (1981) A lipophilic selective α1-adrenoceptor agonist: 2-(2-chloro-5-trifluoromethylphenylimino) imidazolidine (St 587). Life Sci 28:2009–2016

    PubMed  Google Scholar 

  • De Jonge A, Timmermans PBMWM, van Zwieten PA (1983) Quantitative aspects of α adrenergic effects induced by clonidine-like imidazolidines III. Comparison of central and peripheral α1 and α2 adrenoceptors. J Pharmacol Exp Ther 226:565–571

    PubMed  Google Scholar 

  • Delini-Stula A, Baumann P, Buch O (1979) Depression of exploratory activity of clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of alpha-adrenolytic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 307:115–122

    Article  Google Scholar 

  • Dennis T, L'Henreux R, Carter C, Scatton B (1987) Presynaptic alpha-2 adrenoceptor play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J Pharmacol Exp Ther 241:642–649

    PubMed  Google Scholar 

  • Franklin KBJ, Herberg LJ (1977) Presynaptic alpha-adrenoceptors: the depression of self-stimulation by clonidine and its restoration by piperoxane but not by phentolamine or phenoxybenzamine. Eur J Pharmacol 43:33–38

    Article  PubMed  Google Scholar 

  • Hauser D, Closse A (1978)3H-clozapine binding to rat brain membranes. Life Sci 23:557–562

    Article  PubMed  Google Scholar 

  • Hayes AG, Skingle M, Tyers MB (1986) Antagonism of alpha-adrenoceptor agonist-induced antinociception in the rat. Neuropharmacology 25:397–402

    Article  PubMed  Google Scholar 

  • Hieble JP, De Marines M, Fowler PJ, Matthews WD (1986) Selective alpha-2 adrenoceptor blockade by SKF 86466; in vitro characterization of receptor selectivity. J Pharmacol Exp Ther 236:90–96

    PubMed  Google Scholar 

  • Hieble JP, Sarau HM, Foley JJ, De Marinis RM, Pendleton RG (1982) Comparison of central and peripheral α1-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 318:267–273

    Google Scholar 

  • Hornung R, Presek P, Glossmann H (1979) Alpha adrenoceptors in rat brain: Direct identification with prazosin. Naunyn-Schmiedeberg's Arch Pharmacol 308:223–230

    Article  Google Scholar 

  • Katz JL (1984) Effects of clonidine and some α-adrenergic antagonists alone and in combination on schedule controlled behavior in pigeons and mice. Psychopharmacology 83:38–43

    Article  PubMed  Google Scholar 

  • Langer SZ (1981) Presynaptic regulation of the release of catecholamines. Pharmacol Rev 32:337–362

    Google Scholar 

  • Marwaha J, Aghajanian GK (1982) Typical and atypical neuroleptics are potent antagonists at α1-adrenoceptors of the dorsal lateral geniculate nucleus. Naunyn-Schmiedeberg's Arch Pharmacol 321:32–37

    Article  Google Scholar 

  • van Meel JCA, De Jonge A, Timmermans PBMWM, van Zwieten PA (1981) Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat. J Pharmacol Exp Ther 219:760–767

    PubMed  Google Scholar 

  • Menon MK, Kodama CK, Kling AS, Fitten J (1986) An in vivo pharmacological method for the quantitative evaluation of the central effects of alpha-1 adrenoceptor agonists and antagonists. Neuropharmacology 25:503–508

    Article  PubMed  Google Scholar 

  • Menon MK, Dinovo EC, Haddox VG (1987) Modification of certain pharmacological effects of ethanol by lipophilic alpha-1 adrenergic agonists. Life Sci 41:1599–1610

    Article  PubMed  Google Scholar 

  • Menon MK, Gordon LI, Fitten J (1988) Interaction between clozapine and a lipophilic α1-adrenergic agonist. Life Sci 43:1791–1804

    Article  PubMed  Google Scholar 

  • Nomura Y, Oki K, Segawa T (1980) Pharmacological characterization of central alpha-adrenoceptors which mediate clonidine-induced locomotor hyperactivity in the developing rat. Naunyn-Schmiedeberg's Arch Pharmacol 311:41–44

    Article  Google Scholar 

  • Paalzow G, Paalzow L (1976) Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Naunyn-Schmiedeberg's Arch Pharmacol 292:119–126

    Article  Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effects at brain serotonin, α-adrenergic and histamine receptors to clinical potency. Am J Psychiatry 137:1518–1522

    PubMed  Google Scholar 

  • Perry BD, Simons PR, U'Prichard DC (1983) Interactions of neuroleptic compounds at α2-adrenergic receptor affinity sites in bovine caudate nucleus. Eur J Pharmacol 95:315–318

    Article  PubMed  Google Scholar 

  • Petersen EN (1981) Pre- and postsynaptic α-adrenoceptor antagonism by neuroleptics in vivo. Eur J Pharmacol 69:399–405

    Article  PubMed  Google Scholar 

  • Pettibone DJ, Clineschmidt BV, Lotti VJ, Baldwin JJ, Huff JR, Randall WC, Vacca J, Young SD (1987) Pharmacological profile of a new potent and specific α2-adrenoceptor antagonist, L-657,643 Naunyn-Schmiedeberg's Arch Pharmacol 336:169–175

    Article  Google Scholar 

  • Pichler L, Kobinger W (1985) α2-Adrenoceptor blocking properties of the α1-selective agonist 2(2-chloro-5-trifluoromethylphenylimino) imidazolidine (St 587). Arzneimittelforschung 35:201–205

    PubMed  Google Scholar 

  • Robson RD, Antanaccio MJ, Saelans JK, Liebman J (1978) Antagonism by mianserin and classical alpha-adrenoceptor blocking drugs of some cardiovascular and behavioral effects of clonidine. Eur J Pharmacol 47:431–442

    Article  PubMed  Google Scholar 

  • Ruffolo RR, Waddell (1982) Receptor interactions of imidazolines. IX. Cirazoline is an alpha-1 adrenergic agonist and an alpha-2-adrenergic antagonist. J Pharmacol Exp Ther 222:29–36

    PubMed  Google Scholar 

  • Scatton B, Dedak J, Zivkovic B (1983) Lack of involvement of α2-adrenoceptors in the regulation of striatal dopaminergic transmission. Eur J Pharmacol 86:427–433

    Article  PubMed  Google Scholar 

  • Starke K (1977) Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 77:1–124

    PubMed  Google Scholar 

  • Timmermans PBMWM, Matthews WD, Demarinis RM, Hieble JP, Mathy MJ, Doods HN, Thoolen MJMC, De Jonge A, Wilffert B, Van Zwietan PA (1984) α1-Adrenoceptor-mediated vasoconstriction in vivo to enantiomers of SKF 89748-A. Eur J Pharmacol 101:45–55

    Article  PubMed  Google Scholar 

  • Vizi ES, Harsing LG, Gaal J, Kaposcsi J, Bernath S, Somogyi GT (1986) CH 38083, a selective potent antagonist of alpha-2 adrenoceptors. J Pharmacol Exp Ther 238:701–706

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychopharmacology Research, Veterans Administration Medical Center, 91343, Sepulveda, CA, USA

    M. K. Menon, R. L. Lloyd & L. J. Fitten

  2. Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, 90024, Los Angeles, CA, USA

    M. K. Menon, R. L. Lloyd & L. J. Fitten

Authors
  1. M. K. Menon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. L. Lloyd
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. J. Fitten
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Menon, M.K., Lloyd, R.L. & Fitten, L.J. Antagonism of the hypothermic effect of clozapine in mice by centrally-active α2-adrenergic antagonists and α1-adrenergic agonists. Psychopharmacology 101, 67–72 (1990). https://doi.org/10.1007/BF02253720

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02253720

Key words

Search

Navigation